Search Results
Mar 04, 2026, 10:56 ET Thunder Power Holdings, Inc. Announces Share Exchange Approval by Taiwanese Government
ability to obtain and maintain required additional regulatory, governmental, and shareholder approvals and to satisfy remaining closing conditions; (iii) successful transfer of acquired asset ownership and timely operational integration; (iv) loss of key management or project personnel; (v) unexpected
More news about: Thunder Power Holdings, Inc.
Mar 04, 2026, 10:50 ET Kelsey H. Collins, PhD, Wins NEXT Award for Translational Research on Relationship between Fat and Osteoarthritis Development and Pain
Accessed Jan. 12, 2026.ii Hawker GA. 2019. Osteoarthritis is a serious disease. Clin Exp Rheumatol 37 Suppl 120:3-6.iii Griffin TM, Huebner JL, Kraus VB, Guilak F. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 10:41 ET In HelloNation, Dental Expert Dr. John Morgan Jackson III, D.M.D. Compares Professional Teeth Whitening & At-Home Kits
an article featuring insights from Dr. John Morgan Jackson III, D.M.D., of Jackson & Jackson Dental in LaGrange, GA.The HelloNation article explains that many people in LaGrange consider at-home whitening
More news about: HelloNation
Mar 04, 2026, 10:40 ET Combat Veteran, Navy Orthopaedic Surgeon Receives OREF Clinical Research Award for On-the-Ground Research Leading to Evolution of Battlefield Orthopaedic Care, Reduced Morbidity and Mortality
https://www.defense.gov/casualty.pdf. Published Jan. 30, 2025. Accessed Jan. 12, 2026.iii Owens, BD, Kragh JF, Wenke JC, et al. 2008. Combat wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma. 64(2):295–299.iv Covey
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 10:30 ET ORBIT Award Presented to Robert L. LaPrade, MD, PhD, FAAOS, for 20 Years of Research to Advance Posterior Cruciate Ligament Injury Diagnosis, Treatment and Rehabilitation
Isolated PCL Injuries Improve From Surgery as Much as Patients With ACL Injuries After 2 Years. Orthop J Sports Med 3:2325967115599539.iii Gill TJ, DeFrate LE, Wang C, et al. 2004. The effect of posterior cruciate ligament reconstruction on patellofemoral contact pressures in the knee
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 09:54 ET Marco's Pizza Targets 80+ New Stores in 2026 After Disciplined Growth and Innovation in 2025
This information excludes (i) international locations (including Puerto Rico); (ii) Franchised Stores not open for the entire 52-week period in 2024; (iii) special venue and non-traditional franchised locations; and (iv) Franchised Stores that closed in 2024. See Item 19 of our 2025 Franchise Disclosure
More news about: Marco's Pizza
Mar 04, 2026, 09:15 ET Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR‑T Therapy in High‑Risk Diffuse Large B‑Cell Lymphoma
diftitox‑cxdl)LYMPHIR is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma (CTCL) indicated for use in Stage I-III disease after at least one prior systemic therapy. It is a recombinant fusion protein that combines the IL-2 receptor binding domain with diphtheria
More news about: Citius Oncology, Inc.
Mar 04, 2026, 09:00 ET LEVI & KORSINSKY, LLP: RARE STOCK DECLINED OVER 42% FOLLOWING PHASE III STUDY FAILURE DISCLOSURE
26, 2025, Ultragenyx shares plummeted to $19.72 on December 29, 2025---a decline of approximately 42.32%---as the Company disclosed that both Phase III Orbit and Cosmic studies failed to achieve statistical significance against their primary endpoints of reduced annualized fracture rates.
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 13, 2026 in CoreWeave, Inc. Lawsuit - CRWV
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; (iv) as a result, the Company's public statements were
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 09:00 ET Levi & Korsinsky Notifies Beyond Meat, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BYND
material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the SEC; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a loss
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 09:00 ET Enphase Energy, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 20, 2026 to Discuss Your Rights - ENPH
its ability to manage its channel inventory; (ii) Enphase overstated its ability to mitigate effects arising from the termination of the 25D Credit; (iii) accordingly, Enphase overstated its financial and operational prospects; and (iv) as a result, the Company's public statements were materially false
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 09:00 ET Levi & Korsinsky Notifies Plug Power Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PLUG
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 09:00 ET Lakeland Industries, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LAKE
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Levi & Korsinsky, LLP
Mar 04, 2026, 08:52 ET Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
clinical value through real-world application and validation across multiple Phase III trials. The drug is currently involved in over 11 Phase III/registration clinical studies including global programs such as a Phase III registrational trial for the first-line treatment of gastric cancer, and a Phase
More news about: Akeso, Inc.
Mar 04, 2026, 08:49 ET Lotus Domaine Fund III, LP Announces Strategic Investment Relationship with OPENVC Fund I, LP
NEWPORT BEACH, Calif., March 4, 2026 /PRNewswire/ -- Lotus Domaine Fund III, LP, a private equity fund focused on founder-led enterprise technology companies, today announced that it has entered into a finalized strategic
More news about: Lotus Domaine
Mar 04, 2026, 08:15 ET Suncrete Announces Support Agreements with a Majority of Warrantholders
Combination, the combined company will be named Suncrete, Inc. ("PubCo") and will trade on Nasdaq under the ticker symbol "RMIX."Ned N. Fleming, III, Executive Chairman of Suncrete, commented, "We are pleased to have secured support agreements with warrantholders of Haymaker representing the majority
More news about: Suncrete
Mar 04, 2026, 08:05 ET INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
and first-line cervical cancer. The drug has also been investigated in over 30 clinical trials spanning more than 20 tumor types. Currently, 11 Phase III or registrational trials are ongoing, with three already having met primary endpoints. With a novel dual-targeting mechanism against PD-1 and CTLA-4,
More news about: INOVIO Pharmaceuticals, Inc.
Mar 04, 2026, 08:00 ET Antheia Secures Additional $9 Million in Expanded BioMaP-Consortium Project Agreement to Onshore Pharmaceutical Supply Chains
Strategic Preparedness and Response (ASPR); Office of Industrial Base Manufacturing and Supply Chain (IBMSC); Defense Production Act Title III Program (DPA Title III), under Other Transaction Authority agreement number #75A50123D00003 via BARDA's Biopharmaceutical Manufacturing Preparedness (BioMaP) OTA
More news about: Antheia
Mar 04, 2026, 08:00 ET ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
of consumers receiving GLP-1 medications obtain them from providers who also offer aesthetic treatments, up from 49% in late 2024iii.IRVINE, Calif., March 4, 2026 /PRNewswire/ -- Allergan
More news about: AbbVie
Mar 04, 2026, 07:25 ET Natural Grocers® Celebrates Oregon Day with a Special Gift and Savings March 8-10, 2026
details via {N}power email or app. Must present phone number at checkout to accumulate towards the minimum requirement in one transaction.[iii] Sign up by 3/5/2026 to receive this coupon via email or app. {N}power offers are available only to registered members and are subject to program
More news about: Natural Grocers by Vitamin Cottage, Inc.
Mar 04, 2026, 07:00 ET /R E P E A T -- VERSABANK REPORTS STRONG FIRST QUARTER RESULTS: ACCELERATED U.S. GROWTH DRIVES 31% YEAR-OVER-YEAR INCREASE IN REVENUE, 36% YEAR-OVER-YEAR GROWTH IN NET INCOME, 49% YEAR-OVER-YEAR GROWTH IN ADJUSTED NET INCOME/
** Capital management and leverage measures are in accordance with OSFI's Capital Adequacy Requirements and Basel III Accord.SEGMENTED FINANCIAL SUMMARY – QUARTERLY
More news about: VersaBank
Mar 04, 2026, 05:45 ET MDA SPACE REPORTS FOURTH QUARTER AND FISCAL 2025 RESULTS
measures.We define EBITDA as net income (loss) before: i) depreciation and amortization expenses, ii) provision for (recovery of) income taxes, and iii) finance costs. Adjusted EBITDA is calculated by adding to and deducting from EBITDA, as applicable, certain expenses, costs, charges or benefits incurred
More news about: MDA Space
Mar 04, 2026, 04:58 ET Global Times: The power of win-win cooperation: What does the wave of China's NEVs bring to the world?
joined Volkswagen Anhui in 2021 and has personally participated in building systems and capabilities "from the ground up." By the end of 2025, the Phase III project of Volkswagen Group China Technology Company (VCTC) was successfully put into operation in Hefei.This R&D center holds direct product
More news about: Global Times
Mar 03, 2026, 22:47 ET Tierra Mojada Luxembourg II S.à r.l. announces commencement of a consent solicitation for its 5.750% Senior Secured Notes due 2040
the Solicitation Agents and the Information & Tabulation Agent; (ii) to extend such Consent Solicitation for any reason from time to time; and (iii) not to extend such Consent Solicitation beyond the original Expiration Time or any date to which such Consent Solicitation has been previously extended.Mizuho
More news about: Tierra Mojada Luxembourg II S.à r.l.
Mar 03, 2026, 20:22 ET VERSABANK REPORTS STRONG FIRST QUARTER RESULTS: ACCELERATED U.S. GROWTH DRIVES 31% YEAR-OVER-YEAR INCREASE IN REVENUE, 36% YEAR-OVER-YEAR GROWTH IN NET INCOME, 49% YEAR-OVER-YEAR GROWTH IN ADJUSTED NET INCOME
** Capital management and leverage measures are in accordance with OSFI's Capital Adequacy Requirements and Basel III Accord.SEGMENTED FINANCIAL SUMMARY – QUARTERLY
More news about: VersaBank